Parkinson's disease GWAS-linked Park16 variant is associated with a lower risk of cognitive impairment: a 4-year observational study.
Sign Up to like & getrecommendations! Published in 2023 at "European journal of neurology"
DOI: 10.1111/ene.15893
Abstract: BACKGROUND Genome wide association study (GWAS)-linked variant (Park16 rs6679073) modulates the risk of Parkinson's disease (PD). We postulate that there may be differences in clinical characteristics between Park16 rs6679073 carriers and non-carriers. AIM In a… read more here.
Keywords: year; park16 rs6679073; parkinson disease; gwas linked ... See more keywords
Parkinson’s disease GWAS-linked Park16 carriers show greater motor progression
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Medical Genetics"
DOI: 10.1136/jmedgenet-2018-105661
Abstract: Background Data on the long-term motor outcomes of genome-wide association study (GWAS)-linked Parkinson disease (PD) carriers are useful for clinical management. Objectives To characterise the association between GWAS-linked PARK16 gene variant and disease progression in… read more here.
Keywords: progression; gwas linked; motor; parkinson disease ... See more keywords